VolitionRx Limited (VNRX) Stock Price, Quote & AI Analysis

Live VNRX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for VolitionRx Limited.

TradeVae provides AI-driven analysis and real-time market intelligence for VolitionRx Limited (VNRX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

VNRX
VolitionRx Limited
real-time
$0.00 +0.00 (+0.00%)
Open
2.620000
High
2.780000
Low
2.340000
Volume
1,009,302
VWAP
-
Market Cap
$18,844,935.15
52W Range
$2.17 - $18.80
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 13, 2026 Q1
Market
EPS Estimate: $-0.0408
Revenue Estimate: $863,532.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

VolitionRx Limited's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

VolitionRx Limited Overview

Company information

Company Overview

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Company Details
Market Cap
$19.90M
Shares Outstanding
8,087,960
Weighted Shares Outstanding
8,087,955
CEO
Cameron John Reynolds
Address
1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, 89014
Employees
75
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
XASE

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

VolitionRx Limited Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...